Article Sidebar

PDF (Tiếng Việt)
Published: 2022-06-01
Abstract Views: 343
Views PDF (Tiếng Việt): 560
DOI: https://doi.org/10.52852/tcncyh.v153i5.864
Issue
Vol. 153 No. 5 (2022)
Section
Các bài báo
How to Cite
An, N. H. ., Lưu, V. Đăng ., Tôn, M. D. ., & Thông, P. M. . (2022). 22. Standard thrombectomy versus combined intravenous thrombolysis and thrombectomy: a systematic review and meta-analysis. Journal of Medical Research, 153(5), 180-190. https://doi.org/10.52852/tcncyh.v153i5.864

22. Standard thrombectomy versus combined intravenous thrombolysis and thrombectomy: a systematic review and meta-analysis

Nguyen Huu An, Vu Dang Luu, Mai Duy Ton, Pham Minh Thong

Main Article Content

Abstract

This is asystematic review and meta-analysis of randomized controlled trials (RCTs) conducted to elucidate if pre-treatment with intravenous thrombolysis is necessary before thrombectomy. A total of 6 RCTs conducted from January 2019 to March 2022 were selected to meta-analyze, including DIRECT-MT trial, DEVT trial, SKIP trial, MR CLEAN-NO IV trial, SWIFT-DIRECT trial, and DIRECT-SAFE trial. In terms of good outcomes (mRS 0-2 at 90 days), thrombectomy alone was non-inferior to combination therapy at the non-inferiority margin of -6%. The successful reperfusion rates were lower in thrombectomy alone, but symptomatic intracerebral hemorrhage rates were also lower in this therapy. Thrombectomy alone may be a reasonable option for patients at high risk of hemorrhagic transformation following revascularization.

Article Details

Keywords

thrombectomy alone, combined intravenous thrombolysis and thrombectomy, systematic review, meta-analysis

References

1. Feigin VL, Abajobir A, Abate K, et al. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877-897.
2. National institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1588.
3. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372:11-20.
4. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030.
5. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-2295.
6. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-1018.
7. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-2306.
8. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019; 50(12): e344-e418.
9. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31.
10. Chandra RV, Leslie-Mazwi TM, Mehta BP, et al. Does the use of IV tPA in the current era of rapid and predictable recanalization by mechanical embolectomy represent good value?. Journal of neurointerventional surgery. 2016 May 1;8(5):443-6.
11. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015 Dec;4(1):1-9.
12. Miller SA. Enhancing your practice through evidence - based decision making: PICO, learning how to ask good questions. The Journal of Evidenced - Based Dental Practice. 2001;1(2):p.136-141.
13. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
14. Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. NEJM. 2020;382(21):1981-93. doi: 10.1056/NEJMoa 2001123.
15. Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA. 2021;325(3):234-43. doi: 10.1001/jama.2020. 23523.
16. Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA. 2021;325(3):244-53. doi: 10.1001/jama. 2020.23522.
17. LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke. NEJM. 2021;11;385(20):1833-44. doi: 10.1056/NEJMoa2107727.
18. Fisher U, Gralla J. SWIFT-DIRECT Study Investigators. Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation stroke. European Stroke Organisation Conference; September 2021.
19. Peter Mitchell, Bernard Yan. DIRECT SAFE: A randomized controlled trial of DIRECT endovascular clot retrieval versus standard bridging thrombolysis with endovascular clot retrieval within 4,5 hours of stroke onset. World Stroke Congress; October 28 2021.
20. Lin CJ, Saver JL. Noninferiority margins in trials of thrombectomy devices for acute ischemic stroke: is the bar being set too low? Stroke. 2019 Dec;50(12):3519-26.
21. Yoon W, Kim SK, Park MS, et al. Predictive factors for good outcome and mortality after stent-retriever thrombectomy in patients with acute anterior circulation stroke. J Stroke. 2017;19(1):97.